《糖尿病诊断和管理中实验室分析的指南和建议》执行摘要
该指南由专家委员会基于证据制定,并经AACC和ADA等机构评审,针对糖尿病诊断与管理中的实验室检测提出推荐。内容涵盖血糖和Hb A1c诊断、自我血糖监测与持续葡萄糖监测、Hb A1c实验室分析,以及非侵入性葡萄糖监测、基因检测、酮体、自身抗体、尿白蛋白、胰岛素、胰岛素原和C肽的潜在作用。部分分析物目前临床价值有限,不推荐检测。
要点
- 糖尿病可依据静脉血浆葡萄糖浓度升高或血Hb A1c升高诊断。
- 血糖控制通过患者使用血糖仪和/或持续组织间葡萄糖监测装置自测血糖及实验室Hb A1c分析来监测。
- 部分分析物目前临床价值有限,不推荐检测。
核心结论
- 指南基于已发表数据或专家共识提供具体推荐,部分分析物目前临床价值有限,不推荐检测。
研究设计与样本
- 专家委员会编制基于证据的推荐,评估证据总体质量和推荐强度,经受邀评审和公开评论后由AACC证据为基础实验室医学委员会及董事会和ADA专业实践委员会评审。
主要发现
- 糖尿病可通过静脉血浆葡萄糖浓度升高或血Hb A1c升高诊断。
- 血糖控制通过患者使用血糖仪和/或持续组织间葡萄糖监测装置自测血糖以及实验室Hb A1c分析来监测。
- 指南涉及非侵入性葡萄糖监测、基因检测以及酮体、自身抗体、尿白蛋白、胰岛素、胰岛素原和C肽测量的潜在作用。
临床怎么用
- 临床可依据静脉血浆葡萄糖或Hb A1c诊断糖尿病,并使用血糖仪、持续葡萄糖监测装置和实验室Hb A1c监测血糖控制。
- 对于目前临床价值有限的分析物,不推荐检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Numerous laboratory tests are used in the diagnosis and management of patients with diabetes mellitus. The quality of the scientific evidence supporting the use of these assays varies substantially. An expert committee compiled evidence-based recommendations for laboratory analysis in patients with diabetes. The overall quality of the evidence and the strength of the recommendations were evaluated. The draft consensus recommendations were evaluated by invited reviewers and presented for public comment. Suggestions were incorporated as deemed appropriate by the authors (see Acknowledgments in the full version of the guideline). The guidelines were reviewed by the Evidence Based Laboratory Medicine Committee and the Board of Directors of the American Association of Clinical Chemistry and by the Professional Practice Committee of the American Diabetes Association. CONTENT: Diabetes can be diagnosed by demonstrating increased concentrations of glucose in venous plasma or increased hemoglobin A1c (Hb A1c) in the blood. Glycemic control is monitored by the patients measuring their own blood glucose with meters and/or with continuous interstitial glucose monitoring devices and also by laboratory analysis of Hb A1c. The potential roles of noninvasive glucose monitoring; genetic testing; and measurement of ketones, autoantibodies, urine albumin, insulin, proinsulin, and C-peptide are addressed. SUMMARY: The guidelines provide specific recommendations based on published data or derived from expert consensus. Several analytes are found to have minimal clinical value at the present time, and measurement of them is not recommended.
引用
- Sacks DB, Arnold M, Bakris GL, et al. Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Clin Chem. 2023. PMID: 37562009. doi:10.1093/clinchem/hvad079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。